Walgreens to pay ~$5B to settle nationwide opioid-related claims
AndreyPopov/iStock via Getty Images


Walgreens (NASDAQ:WBA) on Wednesday agreed to pay up to ~$4.95B as part of a multi-state settlement to resolve most of the opioid-related litigation the company was facing. The announcement comes hours after the rival pharmacy chain CVS Health (CVS) announced a similar deal.

Per the terms, Walgreens (WBA) will pay up to approximately $4.95B over 15 years to settle with states, tribes, and other administrative entities that agree to participate in the agreement.

The deal does not include any âadmission of wrongdoing or liability by the company,â Walgreens (WBA) added.
The agreement CVS (CVS) proposed involves the payment of about $5B over the next ten years starting from 2023. As part of its deal, states and political entities such as counties and cities will receive $4.9B, and U.S. tribes are entitled to $130M.